The role of dopamine in cognitive sequence learning: evidence from Parkinson’s disease
| Autor: | Jacob I. Sage, Steven Grossman, Catherine E. Myers, Mark A. Gluck, Daphna Shohamy |
|---|---|
| Rok vydání: | 2005 |
| Předmět: |
Male
Levodopa Parkinson's disease Dopamine education Nigrostriatal pathway Neuropsychological Tests Serial Learning Antiparkinson Agents Behavioral Neuroscience Cognition medicine Humans Association (psychology) Aged Analysis of Variance Memoria Parkinson Disease Middle Aged medicine.disease medicine.anatomical_structure Conditioning Operant Female Sequence learning Psychology Neuroscience medicine.drug |
| Zdroj: | Behavioural Brain Research. 156:191-199 |
| ISSN: | 0166-4328 |
| Popis: | Electrophysiological and computational studies suggest that nigro-striatal dopamine may play an important role in learning about sequences of environmentally important stimuli, particularly when this learning is based upon step-by-step associations between stimuli, such as in second-order conditioning. If so, one would predict that disruption of the midbrain dopamine system — such as occurs in Parkinson’s disease — may lead to deficits on tasks that rely upon such learning processes. This hypothesis was tested using a “chaining” task, in which each additional link in a sequence of stimuli leading to reward is trained step-by-step, until a full sequence is learned. We further examined how medication (L-dopa) affects this type of learning. As predicted, we found that Parkinson’s patients tested ‘off’ L-dopa performed as well as controls during the first phase of this task, when required to learn a simple stimulus–response association, but were impaired at learning the full sequence of stimuli. In contrast, we found that Parkinson’s patients tested ‘on’ L-dopa performed better than those tested ‘off’, and no worse than controls, on all phases of the task. These findings suggest that the loss of dopamine that occurs in Parkinson’s disease can lead to specific learning impairments that are predicted by electrophysiological and computational studies, and that enhancing dopamine levels with L-dopa alleviates this deficit. This last result raises questions regarding the mechanisms by which midbrain dopamine modulates learning in Parkinson’s disease, and how L-dopa affects these processes. © 2004 Elsevier B.V. All rights reserved. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect